Health Media Articles
Excerpts of Key Health Media Articles from Major Media
Below are many highly revealing excerpts of important health articles reported in the mainstream media suggesting a cover-up.
Links are provided to the full articles on major media websites. If any link should fail to function, click here
. These health articles are listed by article date. For the same list by order of importance, click here
. For the list by date posted, click here
. By choosing to educate ourselves on these important issues and to spread the word
, we can and will build a brighter future
For an index to revealing excerpts of media articles on several dozen engaging topics, click here
US rice farmers sue Bayer CropScience over GM rice
Rice farmers in Arkansas, Missouri, Mississippi, Louisiana, Texas and California have sued Bayer CropScience, alleging its genetically modified rice has contaminated the crop. The farmers alleged that the unit of Germany's Bayer AG
failed to prevent its genetically modified rice, which has not been approved for human consumption, from entering the food chain. As a result, they said, Japan and the European Union have placed strict limits on U.S. rice imports and U.S. rice prices have dropped dramatically. U.S. agriculture and food safety authorities learned on July 31 that Bayer's unapproved rice had been found in commercial bins in Arkansas and Missouri. While the United States is a small rice grower, it is one of the world's largest exporters, sending half of its crop to foreign buyers. Japan, the largest importer of U.S. rice, suspended imports of U.S. long-grain rice a week ago. U.S. rice growers are responsible for about 12 percent of world rice trade.
Note: Why did no major media report this important story in the U.S.? Only the Christian Science Monitor mentioned it. The media rarely reports anything negative about genetically modified food. To learn about the dangers of GMOs in the food you eat: http://www.WantToKnow.info/deception10pg
Placebo's power goes beyond the mind
2006-08-21, MSNBC News
For years, scientists have looked at the placebo effect as just a figment of overactive patient imaginations. Sure, dummy medications seemed to curb epileptic seizures, lower blood pressure, soothe migraines and smooth out jerky movements in Parkinson's -- but these people weren't really better. Now, using PET scanners and MRIs ... researchers have discovered that the placebo effect is not "all in patients' heads" but rather, in their brains. New research shows that belief in a dummy treatment leads to changes in brain chemistry. Says Dr. Michael Selzer, professor of neurology at the University of Pennsylvania School of Medicine, "After pooh-poohing this for years, here are studies that show that our thoughts may actually interact with the brain in a physical way." New insights into how placebos work may even help scientists figure out how to harness the effect and teach people to train their own brains to help with healing. Studies in depressed patients ... have found that almost as many are helped by placebo treatments as by actual medications. Researchers are just starting to appreciate the power that the mind can have over the body. Part of what goes into the brain's interpretation is expectation. By changing the expectancy and bumping up the placebo response we might be able to ultimately find a way to provide sustained therapy for chronic pain.
Big Tobacco Lied to Public, Judge Says
2006-08-18, Washington Post
A federal judge ruled yesterday that tobacco companies have violated civil racketeering laws, concluding that cigarette makers conspired for decades to deceive the public about the dangers of their product. But U.S. District Judge Gladys Kessler said that under a 2005 appellate court ruling, she could not impose billions of dollars in penalties that had been sought by the Justice Department in its civil racketeering suit. In the opinion...Kessler wrote that there is "overwhelming evidence" [that the industry] conspired to violate, and indeed violated, federal racketeering laws. "In short," she wrote, "defendants have marketed and sold their lethal product with zeal, with deception, with a single-minded focus on their financial success, and without regard for the human tragedy or social costs that success exacted. Over the course of more than 50 years, defendants lied, misrepresented and deceived the American public, including smokers and the young people...about the devastating health effects of smoking and environmental tobacco smoke." Kessler added that the companies "suppressed research, they destroyed documents, they manipulated the use of nicotine so as to increase and perpetuate addiction...and they abused the legal system in order to achieve their goal -- to make money." The Justice Department lawsuit originally sought $280 billion. But the U.S. Court of Appeals [ruled] a company could not be forced to turn over past profits as a way of preventing future misconduct. The Justice Department subsequently proposed a $130 billion penalty to pay for anti-smoking programs, but...it scaled that back to a total of $14 billion.
Why do some with HIV not get sick?
2006-08-17, MSNBC News
As many as one in 300 HIV patients never get sick and never suffer damage to their immune systems and AIDS experts said on Wednesday they want to know why. Most have gone unnoticed by the top researchers, because they are well, do not need treatment and do not want attention, said Dr. Bruce Walker of Harvard Medical School. But Walker and colleagues want to study these so-called "elite" patients in the hope that their cases can help in the search for a vaccine or treatments. So far Walker and colleagues have not been able to find out why certain people can live for 15 years and longer with the virus and never get ill. The AIDS virus usually kills patients within two years if they are not treated. Walker has tracked down 200 elite patients and has now joined up with other prominent AIDS researchers to find at least 1,000 "elites" in North America and as many as possible globally.
Sickened Iraq Vets Cite Depleted Uranium
2006-08-13, ABC News/Associated Press
A shell coated with depleted uranium pierces a tank like a hot knife through butter. It also leaves behind a fine radioactive dust with a half-life of 4.5 billion years. Depleted uranium is the garbage left from producing enriched uranium for nuclear weapons and energy plants. At Walter Reed Army Medical Center in Washington, D.C., [Herbert Reed] ran into a buddy from his unit. And another, and another. They began to talk. [They] all have depleted uranium in their urine. The veterans, using their positive results as evidence, have sued the U.S. Army, claiming officials knew the hazards of depleted uranium, but concealed the risks. The Department of Defense says depleted uranium is powerful and safe. Military research on mice shows that depleted uranium can enter the bloodstream and come to rest in bones, the brain, kidneys and lymph nodes. Other research in rats shows that DU can result in cancerous tumors and genetic mutations. Fifteen years after it was first used in battle, there is only one U.S. government study monitoring veterans exposed to depleted uranium. Number of soldiers in the survey: 32. Depleted uranium falls into the quagmire of Gulf War Syndrome, from which no treatment has emerged. About 30 percent of the 700,000 men and women who served in the first Gulf War still suffer [this] baffling array of symptoms. Depleted uranium has long been suspected as a possible contributor. It took more than 25 years for the Pentagon to acknowledge that Agent Orange...was linked to [major disease and] sufferings. It took 40 years for the military to compensate sick World War II vets exposed to massive blasts of radiation during tests of the atomic bomb.
Note: Why isn't the media reporting more on this health disaster? For lots more on how veterans suffer from corporate and governmental denial and manipulations, see what a highly decorated U.S. General has to say on the suffering of soldiers at http://www.WantToKnow.info/warcoverup. For an amazingly revealing documentary with interviews from top sources on the depleted uranium cover-up, click here.
Twice as Strong
2006-08-07, Los Angeles Times
When a medical crisis hits, people want to know that someone smart in a white coat can prescribe Prozac to boost their mood, perform heart surgery to open their clogged arteries, or administer chemotherapy, radiation or surgery to cure them of cancer. But growing numbers of Americans are also eager to experiment with alternative therapies. A natural tension has long existed between these two kinds of medicine. Western medical practitioners have been wary of the sometimes wacky-sounding, often-untested therapies in alternative medicine's toolkit. Alternative medicine practitioners have typically operated outside the conventional system, with consumers paying out of pocket. But over the last 10 years this wall has started, partially, to erode. Aided by federal funds, an increasing number of alternative therapies have been put to Western-style clinical tests, separating ones that seem beneficial, such as acupuncture for relief of pain, meditation to reduce hypertension, or ginger to relieve nausea -- from the chaff that appears ineffective. And conventional practitioners have come to appreciate the effect of the mind on chronic pain, heart disease, autoimmune conditions, anxiety and depression -- even the progress of disease.
Medicare drug plan is prescribing profits
2006-08-04, San Francisco Chronicle
Medicare's drug benefit has given a shot in the arm to pharmaceutical companies and insurers, whose revenue is climbing thanks to government subsidies for prescription medicine. What's happened so far: Drugmakers including GlaxoSmithKline and Pfizer reported higher-than-expected sales and profit in the second quarter, with some of the momentum coming from Medicare. Meanwhile, membership rolls of big insurers, including UnitedHealth Group and Humana, are mushrooming as Medicare beneficiaries sign up for drug plans. Drug companies -- which successfully thwarted price-control attempts -- are reaping the rewards of more seniors and disabled people getting access to their medications. British drugmaker GlaxoSmithKline's second-quarter net income grew 14 percent over the same quarter last year due in part to strong Medicare drug sales. Merck & Co., Schering Plough, Wyeth, Roche and Pfizer ... all exceeded analysts' expectations, reflecting sales boosts from the program. In the first three months of the benefit, brand-name drug prices rose 4 percent, according to a report from the AARP. WellPoint Inc., the nation's largest insurer, reported second-quarter profit gains of 34 percent. UnitedHealth ... posted quarterly profit gains of 26 percent. Humana reported earlier this week its second-quarter profit increased 9.9 percent and revenue jumped 52 percent over the same quarter last year, due in large part to a surge in Medicare membership. The insurer expects annual revenue to grow by 50 percent.
Note: This article fails to mention who pays for all these profits -- our tax dollars. To understand the degree of corruption in the pharmaceutical industry, read a two-page summary by one of the most respected MDs in the U.S. at http://www.WantToKnow.info/healthcoverup
Custom-Built Pathogens Raise Bioterror Fears
2006-07-31, Washington Post
In 2002, [a] German-born molecular geneticist startled the scientific world by creating the first live, fully artificial virus in the lab. It was a variation of the bug that causes polio. The virus was made wholly from nonliving parts, using equipment and chemicals on hand. The most crucial part, the genetic code, was picked up for free on the Internet. The new technology opens the door to new tools for defeating disease and saving lives. But today, in hundreds of labs worldwide, it is also possible to transform common intestinal microbes into killers. Or to resurrect bygone killers, such the 1918 influenza. New techniques...allow the creation of synthetic viruses in mere days. Hardware unveiled last year by a Harvard genetics professor can churn out synthetic genes by the thousands, for a few pennies each. The U.S. Centers for Disease Control and Prevention has declined so far to police the booming gene-synthesis industry. "It would be possible -- fully legal -- for a person to produce full-length 1918 influenza virus or Ebola virus genomes," said Richard H. Ebright, a biochemist and professor at Rutgers University. "It is also possible to advertise and to sell the product." Five years after the Sept. 11 attacks, the federal government budgets nearly $8 billion annually -- an 18-fold increase since 2001 -- for the defense of civilians against biological attack. Billions have been spent to develop and stockpile new drugs, most of them each tied to a single, well-known bioterrorism threat, such as anthrax. If successful, [each] drug is a solution for just one disease threat out of a list that is rapidly expanding to include man-made varieties.
Note: The government research lab at Fort Detrick, Maryland, has been secretly developing this technology for decades. For serious questions on the role of secret government projects in deadly disease creation and dissemination, see http://www.WantToKnow.info/resources#emerging or click here.
Drug firms a danger to health - report
2006-07-26, Guardian (One of U.K.'s leading newspapers)
Drug companies are accused today of endangering public health through widescale marketing malpractices, ranging from covertly attempting to persuade consumers that they are ill to bribing doctors and misrepresenting the results of safety and efficacy tests on their products. In a report that charts the scale of illicit practices by drug companies in the UK and across Europe, Consumers International - the world federation of consumer organisations - says people are not being given facts about the medicines they take because the companies hide the marketing tactics on which they spend billions. "Irresponsible marketing practices form a serious, persistent and widespread problem among the entire pharmaceutical industry," says the report, which analyses the conduct of 20 of the biggest companies. Scandals such as the withdrawal of Vioxx ... show that unethical drug promotion is a consumer concern. Merck withdrew the drug in September 2004, but allegedly knew it could increase the chances of heart attacks and strokes from 2000 and has been accused of manipulating study results to play down the risk. More than 6,000 lawsuits have been filed against the company in the United States by people who claim they suffered heart attacks as a result of the drug. There is no room for complacency when drug companies spend twice as much on marketing as on research...but do not publish information on their drug promotion practices.
A Windfall From Shifts to Medicare
2006-07-18, New York Times
The pharmaceutical industry is beginning to reap a windfall from a surprisingly lucrative niche market: drugs for poor people. The windfall, which by some estimates could be $2 billion or more this year, is a result of the transfer of millions of low-income people into the new Medicare Part D drug program that went into effect in January. Under that program...the prices paid by insurers, and eventually the taxpayer, for the medications given to those transferred are likely to be higher than what was paid under the federal-state Medicaid programs. Analysts expect it to generate hundreds of millions of additional dollars this year for the drug companies. Drugs tend to be cheaper under the Medicaid programs because the states are the buyers and by law they receive the lowest available prices for drugs. But in creating the federal Part D program, Congress -- in what critics saw as a sop to the drug industry -- barred the government from having a negotiating role. The windfall for the drug makers was made possible by a provision of the 2003 Medicare law that exempts Part D drugs from "best price" rebates that the drug makers have been required to give to the state Medicaid programs. Those rebates are meant to make sure that state Medicaid agencies pay no more than the best prices drug companies offer to any big commercial insurer. Now, under Part D, all sorts of price deals will be negotiated by dozens of Medicare drug plans. The prices will be reported to Medicare, but under a provision of the law pushed by industry lobbyists, they will otherwise be kept secret.
Medical Journal Says It Was Again Misled
2006-07-12, New York Times/Associated Press
For the second time in two months, The Journal of the American Medical Association says it was misled by researchers who failed to reveal financial ties to drug companies. The latest incident, disclosed in letters to the editor and a correction in Wednesday's journal, involves a study showing that pregnant women who stop taking antidepressants risk slipping back into depression. Most of the 13 authors have financial ties to drug companies including antidepressant makers, but only two of them revealed their ties when the study was published in February.
Note: To understand how the drug companies manipulate results and even exert tremendous influence over the U.S. Congress, see http://www.WantToKnow.info/healthcoverup
Beyond Genetically Modified Crops
2006-07-12, Washington Post
For years the life science companies...have argued that genetically modified food is the next great scientific and technological revolution in agriculture. Nongovernmental organizations...have been cast as the villains in this unfolding agricultural drama...accused of continually blocking scientific and technological progress because of...opposition to genetically modified food. Now, in an ironic twist, new, cutting-edge technologies have made gene splicing and transgenic crops obsolete. The new frontier is called genomics, and the new agricultural technology is called marker-assisted selection, or MAS. This technology offers a sophisticated method to greatly accelerate classical breeding. A growing number of scientists believe that MAS...will eventually replace genetically modified food. Environmental organizations that have long opposed genetically modified crops are guardedly supportive of MAS technology. Rapidly accumulating information about crop genomes is allowing scientists to [use] MAS to locate desired traits in other varieties of a particular food crop, or its relatives that grow in the wild. Then they cross-breed those related plants with the existing commercial varieties to improve the crop. With MAS, the breeding of new varieties always remain within a species, thus greatly reducing the risk of environmental harm and potential adverse health effects associated with genetically modified crops. If properly used as part of a much larger systemic and holistic approach to sustainable agricultural development, MAS technology could be the right technology at the right time in history.
Note: For astonishing information on the dangers to your health of genetically modified foods, see the most popular document on our website in recent months at http://www.WantToKnow.info/deception10pg
Artificial Blood Experiment: Is Your City Participating?
2006-07-07, ABC News
Northfield Lab's experimental blood substitute Polyheme is currently in randomized phase III clinical trials recruiting patients without informed consent all over the country. At one point, it was being tested in as many as 27 cities; it is still being tested in 23 hospitals in 20 cities. With the FDA's approval, Northfield Lab has recruited hospitals to participate in the trial study with exemption from informed consent requirements on study participants. Although Northfield Lab claims that extensive information on the study has been made public, a vast majority of the general public has never heard of the trial.
U.S. signs deal to stockpile anti-bird-flu drug
2006-07-01, San Francisco Chronicle
Federal health authorities have signed a two-year deal to help states buy more than half a billion dollars worth of the antiviral drug Tamiflu as a hedge against a pandemic of deadly avian influenza, but there is a catch: States will have to pay for three-quarters of it. Under terms of the deal negotiated with Roche by the Department of Health and Human Services, the states can order up to 31 million packets of Tamiflu -- each containing a 10-pill course of treatment -- for a total cost of $596 million over the next two years. The Bush administration announced late Friday that it had contracted with Swiss drugmaker Roche Laboratories Inc. to supply Tamiflu for stockpiles in all 50 states. The federal government, meanwhile, plans to build its own centralized stockpile. The plan is to have enough antiviral drug in state and federal warehouses by December 2008 to treat 81 million people. Tamiflu is considered by scientists to be the first line of defense against the H5N1 strain of bird flu. The disease is currently confined primarily to chickens, ducks and some wild waterfowl, but researchers fear it could mutate into a form that spreads easily among humans.
Note: No mention is made here that Donald Rumsfeld has already made millions from sales of Tamiflu, and that he was on the board of the company that developed the drug. Many top researchers also believe there is little chance of avian flu mutating. Why are we spending hundreds of millions of dollars to combat a virus which has not even mutated yet? To verify these and other vital facts, see http://www.WantToKnow.info/avianflu
Top Democrat Finds F.D.A.'s Efforts Have Plunged
2006-06-27, New York Times
A 15-month inquiry by a top House Democrat has found that enforcement of the nation's food and drug laws declined sharply during the first five years of the Bush administration. For instance, the investigation found, the number of warning letters that the Food and Drug Administration issued to drug companies, medical device makers and others dropped 54 percent, to 535 in 2005 from 1,154 in 2000. The seizure of mislabeled, defective or dangerous products dipped 44 percent. The research found no evidence that such declines could be attributed to increased compliance with regulations. Investigators at the F.D.A. continued to uncover about the same number of problems at drug and device companies as before...but top officials of the agency increasingly overruled the investigators' enforcement recommendations. The investigation found that by almost every measure, enforcement actions had significantly declined from 2000 to 2005. Dr. Sidney M. Wolfe, director of the Health Research Group at the watchdog organization Public Citizen, noted that the agency now received about $380 million a year in fees from drug makers. "The public," Dr. Wolfe said, "is getting the kind of F.D.A. that the industry is paying for them to get."
Note: For lots more on collusion between government and the medical industry, see our Health Information Center at http://www.WantToKnow.info/healthinformation
Vitamin C: Cancer cure?
2006-06-18, Philadelphia Inquirer (Philadelphia's leading newspaper)
Government nutrition researcher [Dr. Mark Levine] has published new evidence that suggests vitamin C can work like chemotherapy - only better. But so far, he hasn't been able to interest cancer experts in conducting the kind of conclusive studies that, one way or the other, would advance treatment. "If vitamin C is useful in cancer treatment, that's wonderful. If it's not, or if it's harmful, that's fine, too," said Levine, a Harvard-educated physician at the National Institute of Diabetes and Digestive and Kidney Diseases. The distinction between oral and intravenous is crucial. The body automatically gets rid of extra C through urine. Levine's lab has shown that, at high concentrations, the vitamin is toxic to many types of cancer cells in lab dishes. But to get that much C into the body before it's eliminated, it must be put directly into the blood. Five out of nine types of cancer cells that were put in simulated body-cavity fluid died when concentrated ascorbate or peroxide was added to the dish. And the best part: This same lethal marinade had no effect on healthy cells. "Interest is definitely growing," said Kenneth Bock, physician and president of the American College for Advancement in Medicine, an alternative-medicine society that teaches ascorbate infusion protocols. The American Cancer Society and the American Association of Clinical Oncologists warn patients against high-dose C, as do leading cancer centers such as the University of Pennsylvania's and Memorial Sloan-Kettering.
Note: If the above link does not work, the article is also available on the website of the San Diego Union-Tribune. For why this is not making major headlines in the news, click here and here.
The EPA won't release some data on 140 Superfund locations
2006-06-16, Los Angeles Times
At a congressional hearing, Sen. Barbara Boxer (D-Calif.) said the Environmental Protection Agency had designated as confidential the details of about 140 Superfund sites where toxic exposure remained uncontrolled. The secret data included information about how much money and time it would take to clean up the dangerous sites, including one site where the EPA predicted it would take 26 years to close off access to toxics. "This isn't a question of left or right," Boxer said, waving a document marked "Privileged" by EPA officials to prevent its release to the public. "This is a question of right and wrong." The Superfund program was created almost three decades ago in response to environmental disasters such as Love Canal, a neighborhood in Niagara Falls, N.Y., where chemical contamination forced the removal of 800 families and led to $200 million in remediation costs. Those sites are areas where the public still faces some possible exposure to toxic substances -- such as a building near buried radioactive waste that was not surrounded by a fence. A skateboard park built over the site, however, was protected by a layer of dirt. One Republican-sponsored bill moving through Congress would limit data available on toxic substances released into communities, and the U.S. Army Corps of Engineers has blocked information on flooding dangers in Florida.
Note: Major toxic hazards would seem to be a direct threat to the security of those living around the hazards, yet the EPA is keeping these records secret. If you read the entire article, you will see how the LA Times is framing this as a Democrat vs. Republican issue, when it is in fact about public health and safety.
Traumas create unwitting test subjects
2006-06-13, USA Today
With waived-consent studies becoming more prevalent, critics question whether the public understands how they work and whether test subjects get adequate protection. [A] trial, which is reported in today's Journal of the American Medical Association (JAMA), was halted because a device called the AutoPulse, which was used to revive cardiac-arrest victims, failed to save more lives than when rescuers performed cardiopulmonary resuscitation. Patients in these types of studies...are treated under a broad federal rule that allows researchers to test emergency treatments on patients with specific, life-threatening medical conditions without their explicit consent as long as they remain under close watch of independent reviewers. Studies have included large, multi-city, randomized trials, which scientists consider the gold standard for medical research. The [PolyHeme] trial has raised concern among some ethicists and alarm in Congress, where Sen. Charles Grassley, R-Iowa, chairman of the Finance Committee, is conducting an investigation. Grassley is concerned that people who live in the 19 states where PolyHeme is being tested have had inadequate notice about the trial. The FDA requires that community input be sought in the regions around test sites. "It is outrageous that, for all intents and purposes, the FDA allowed a clinical trial to proceed, which makes every citizen in the United States a potential 'guinea pig,' without providing a practical, informative warning to the public," Grassley wrote in a letter to the FDA in February.
Informed Consent Waived in Public Crisis
2006-06-08, CBS News/Associated Press
In a public health emergency, suspected victims would no longer have to give permission before experimental tests could be run to determine why they're sick, under a federal rule published Wednesday. Privacy experts called the exception unnecessary, ripe for abuse and an override of state informed-consent laws. Health care workers will be free to run experimental tests on blood and other samples taken from people who have fallen sick as a result of a bioterrorist attack, bird flu outbreak, detonation of a dirty bomb or any other life-threatening public health emergency, according to the rule issued by the Food and Drug Administration. The rule took effect Wednesday but remains subject to public comment until Aug. 7. The FDA said it published the rule without first seeking comments because it would hinder the response to an outbreak of bird flu or other public health emergency.
Consumer group sues FDA over biotech foods
2006-06-07, San Diego Union Tribune/Reuters
A lawsuit filed Wednesday seeks to force the U.S. government to conduct mandatory reviews of genetically engineered foods and require labeling of such foods once they are approved. The Center for Food Safety's suit against the Food and Drug Administration comes after years of lobbying by environmental and consumer groups for more stringent regulation and labeling of biotech crops. Genetically modified crops, such as soybeans, corn, and canola, are grown widely throughout the United States, and the world leader in development and marketing of the gene-altered crops is...Monsanto. Yet the United States requires no independent testing of these crops or the food products they are used in, does not mandate what data companies must submit for review, and does not require that foods that contain biotech crops be labeled. CFS and more than fifty consumer and environmental groups, filed a legal petition with the FDA in March 2000, asking the agency to adopt a more rigorous approach to biotech food regulation, but the CFS said Wednesday that the FDA had ignored the petition. At various times over the last several years, different scientists, including some within the FDA, have warned that altering the genetic makeup of a food plant by inserting genes from one organism into another...could trigger unexpected food allergies, create toxins in food, or spread antibiotic-resistant disease. CFS said the tests that exposed that potential hazard have not been conducted on any of the genetically modified foods currently marketed.
Note: Many laboratory animals died in scientific tests of GM foods, yet this news has yet to be reported in the major media. If you want to understand the risks involved with the ever-increasing numbers of genetically modified organisms in the food you eat, don't miss: http://www.WantToKnow.info/deception10pg